<div id="readability-page-1">An announcement from VSee Health ( (VSEE) ) is now available.On June 8, 2026, VSee Health, Inc. entered into a securities purchase agreement with an institutional investor and issued an 8% original issue discount secured promissory note with an aggregate principal amount of $271,739.13, bearing 18% annual interest and maturing on December 8, 2026. The note, secured by certain company assets under a security agreement, allows VSee Health to prepay portions of the balance with a 10% prepayment fee and requires full repayment within two business days of receiving proceeds from an equity line of credit with the same investor, highlighting the company’s reliance on structured, privately placed debt financing to manage liquidity and capital structure while avoiding public securities offerings.<div> Spark’s Take on VSEE Stock According to Spark, TipRanks’ AI Analyst, VSEE is a Neutral. The score is primarily weighed down by weak financial performance—large ongoing operating/net losses and continued cash burn—despite manageable current leverage. Technicals also remain bearish with negative MACD and price below key longer-term moving averages. Valuation is hard to support due to a negative P/E, and a large approved equity issuance adds dilution risk. To see Spark’s full report on VSEE stock, click here. </div><div> More about VSee Health VSee Health, Inc. is a Delaware-based company operating in the healthcare sector, with activities that include raising capital through private securities transactions rather than public offerings. Its financing strategy involves secured promissory notes and equity-linked arrangements with institutional investors to support its corporate needs and operations. Average Trading Volume: 1,618,441 Technical Sentiment Signal: Sell Current Market Cap: $7.63M </div><div> For an in-depth examination of VSEE stock, go to TipRanks’ Overview page. </div></div>

VSEE

VSEEW

VSee Health secured $271,739.13 in private debt financing via an 8% OID secured promissory note bearing 18% annual interest, maturing Dec 8, 2026. The deal requires repayment upon equity line proceeds and includes a prepayment option. Spark AI rates VSEE stock as Neutral due to weak financials, cash burn, bearish technicals, and dilution risks from equity issuance.

VSee Health Secures New Private Debt Financing Agreement